A Review of Driver Gene Co-mutations in Prognostic Stratification of Targeted Therapy for Non-Small Cell Lung Cancer
EGFR-TKIs have significantly improved the survival outcomes of patients with EGFR-mutant non-small cell lung cancer (NSCLC). However, substantial heterogeneity in treatment efficacy exists among individuals, and conventional single-gene testing has limitations in guiding therapeutic decision-making. This systematic rev...